Who Paid My Doc
Follistim Aq
Drug Follitropin
NDC 0052-0308-02
General payments
$140,634
Research payments
$0
Through program year 2025, $140,634 in general payments and $0 in research payments were reported against Follistim Aq (Follitropin).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $51,745 | 2,075 |
| 2024 | General | $48,018 | 2,222 |
| 2023 | General | $36,668 | 1,797 |
| 2022 | General | $4,203 | 252 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,346 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.